China National Accord Medicines Corporation Ltd.

SZSE:000028 주식 보고서

시가총액: CN¥15.2b

China National Accord Medicines 미래 성장

Future 기준 확인 1/6

China National Accord Medicines (는) 각각 연간 6.2% 및 5.7% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 5.6% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 8.3% 로 예상됩니다.

주요 정보

6.2%

수익 성장률

5.6%

EPS 성장률

Healthcare 수익 성장23.1%
매출 성장률5.7%
향후 자기자본 수익률8.3%
애널리스트 커버리지

Good

마지막 업데이트11 Nov 2024

최근 미래 성장 업데이트

China National Accord Medicines Corporation Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 30
China National Accord Medicines Corporation Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results

Apr 10
Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results

Recent updates

Lacklustre Performance Is Driving China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E

Nov 18
Lacklustre Performance Is Driving China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E

China National Accord Medicines Corporation Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 30
China National Accord Medicines Corporation Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

China National Accord Medicines (SZSE:000028) Seems To Use Debt Quite Sensibly

Oct 10
China National Accord Medicines (SZSE:000028) Seems To Use Debt Quite Sensibly

China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E No Reason For Excitement

Aug 13
China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E No Reason For Excitement

Estimating The Intrinsic Value Of China National Accord Medicines Corporation Ltd. (SZSE:000028)

Jul 12
Estimating The Intrinsic Value Of China National Accord Medicines Corporation Ltd. (SZSE:000028)

Is China National Accord Medicines (SZSE:000028) A Risky Investment?

Jun 12
Is China National Accord Medicines (SZSE:000028) A Risky Investment?

Improved Earnings Required Before China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Find Their Feet

May 12
Improved Earnings Required Before China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Find Their Feet

Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results

Apr 10
Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results

China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Could Be 28% Below Their Intrinsic Value Estimate

Mar 15
China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Could Be 28% Below Their Intrinsic Value Estimate

China National Accord Medicines (SZSE:000028) Has A Rock Solid Balance Sheet

Feb 29
China National Accord Medicines (SZSE:000028) Has A Rock Solid Balance Sheet

수익 및 매출 성장 예측

SZSE:000028 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (CNY Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/202685,6501,718N/A1,7006
12/31/202582,1261,615N/A1,6507
12/31/202477,5111,569N/A1,6803
9/30/202475,3581,4752,4522,753N/A
6/30/202474,8761,5122,0732,380N/A
3/31/202475,8811,6261,7692,093N/A
12/31/202375,4771,5992,6152,937N/A
9/30/202375,4121,6291,6561,968N/A
6/30/202375,7021,6432,6743,005N/A
3/31/202374,9791,5972,6722,988N/A
12/31/202273,4431,4872,2382,560N/A
9/30/202272,7651,3101,9312,293N/A
6/30/202271,3241,2691,0981,467N/A
3/31/202269,4591,2601,3601,744N/A
12/31/202168,3581,3361,2851,655N/A
9/30/202166,9791,478592939N/A
6/30/202165,6431,5009701,294N/A
3/31/202162,8751,4821,5791,884N/A
12/31/202059,6491,4021,2091,503N/A
9/30/202056,2441,3062,6632,937N/A
6/30/202054,3581,2622,0582,312N/A
3/31/202053,5391,2171,8652,113N/A
12/31/201952,7871,2681,7612,013N/A
9/30/201950,7791,2431,5461,817N/A
6/30/201947,9431,2181,9652,236N/A
3/31/201944,9371,2171,1401,399N/A
12/31/201843,1221,2111,0671,323N/A
9/30/201841,7511,1821,1101,338N/A
6/30/201841,5171,143N/A1,282N/A
3/31/201841,2981,078N/A923N/A
12/31/201741,2631,058N/A1,285N/A
9/30/201741,4181,080N/A1,155N/A
6/30/201741,2111,084N/A871N/A
3/31/201741,1591,205N/A959N/A
12/31/201641,2481,187N/A1,472N/A
9/30/201649,2491,263N/A1,878N/A
6/30/201645,5681,199N/A1,839N/A
3/31/201641,870984N/A1,286N/A
12/31/201537,819928N/A1,457N/A
9/30/201525,740721N/A201N/A
6/30/201525,155693N/A136N/A
3/31/201524,683682N/A-189N/A
12/31/201423,954652N/A-797N/A
9/30/201423,418629N/A-369N/A
6/30/201422,680607N/A-258N/A
3/31/201421,864545N/A-70N/A
12/31/201321,199520N/A465N/A

애널리스트 미래 성장 예측

수입 대 저축률: 000028 의 연간 예상 수익 증가율( 6.2% )이 saving rate( 2.8% 보다 높습니다. ).

수익 vs 시장: 000028 의 연간 수익( 6.2% ) CN 시장( 26.3% 보다 느리게 성장할 것으로 예상됩니다. 26.3% 연간).

고성장 수익: 000028 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: 000028 의 수익(연간 5.7% ) CN 시장( 13.9% 보다 느리게 성장할 것으로 예상됩니다. 13.9% 연간).

고성장 수익: 000028 의 수익(연간 5.7% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: 000028 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 8.3 %).

성장 기업 발견

7D

1Y

7D

1Y

7D

1Y